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The interest in using quantum dots (QDots) as highly fluorescent and photostable nanoparticles in 
biomedicine is vastly increasing. One major hurdle that slows down the (pre)clinical translation of 
QDots is their potential toxicity. Several strategies have been employed to optimize common core-
shell QDots, such as the use of gradient alloy (GA)-QDots. These particles no longer have a size-
dependent emission wavelength, but the emission rather depends on the chemical composition of the 
gradient layer. Therefore, particles of identical sizes but with emission maxima spanning the entire 
visible spectrum can be generated. In the present study, two types of GA-QDots are studied with 
respect to their cytotoxicity and cellular uptake. A multiparametric cytotoxicity approach reveals 
concentration-dependent effects on cell viability, oxidative stress, cell morphology and cell 
functionality (stem cell differentiation and neurite outgrowth), where the particles are very robust 
against environmentally-induced breakdown. Non-toxic concentrations are defined and compared to 
common core-shell QDots analyzed under identical conditions. Additionally, this value is translated 
into a functional value by analyzing the potential of the particles for cell visualization. Interestingly, 
these particles result in clear endosomal localization, where different particles result in identical 
intracellular distributions. This is in contrast with CdTe QDots with the same surface coating, which 
resulted in clearly distinct intracellular distributions as a result of differences in nanoparticle diameter. 
The GA-QDots are therefore ideal platforms for cell labeling studies given their high brightness, low 
cytotoxicity and identical sizes, resulting in highly similar intracellular particle distributions which 




In the field of nanomedical research, quantum dots (QDots) take an important place as powerful 
probes for fluorescence imaging [1-3]. QDots are colloidal nanocrystals with a core diameter that 
ranges between 1 and 10 nm and that are built up of semiconductor materials, typically combinations 
of groups 12 and 16 (e.g. CdTe, CdSe, ZnS). QDots possess excellent fluorescent properties such as a 
high photostability, very high brightness and very narrowand sizetunable emission spectra [4]. These 
properties enable a broad range of applications such as multiplexed imaging of fixed cells, tissues and 
even clinical tissue samples, enhancing the predictability of outcome of cancer progression at more 
early stages [5,6]. Owing to their high photostability and brightness, QDots are also extensively used 
for kinetic single molecule studies on cellular proteins such as kinesin or individual glycine receptors, 
providing detailed information on their intracellular mobility and processing that was not previously 
possible using organic fluorophores [7,8]. 
In biomedical research, Cd2+-containing QDots are most commonly used as they possess superb 
optical properties and synthesis protocols have been well-described [9]. Both core-only (e.g. CdTe) or 
core-shell QDots exist (e.g. CdSe/ZnS) where the shell layer passivates the core, enhancing its optical 
properties and typically rendering the QDots more compatible with a biological environment by 
shielding the Cd2þ-containing core from the environment [10]. Although these Cd2+-containing 
QDots have proven to have a lot of potential for a broad variety of biomedical applications, they 
currently remain limited to proof-of-concept studies. One major hurdle concerning the full exploitation 
of Cd2+-containing QDots is their potential toxicity, derived from the high toxicity of free Cd2+ ions 
[11]. Although the gradual release of toxic ions can be exploited for biomedical purposes such as 
cancer therapy [12], it may also inadvertently affect healthy cells as long as this process remains only 
partially understood. A lot of attention has been put in determining the potential toxicity of Cd2+-
containing QDots, but thus far, the safety of these NPs remains questionable due to several intrinsic 
difficulties that are associated with assessing NP safety: 1) the wide number of variations in QDot 
parameters (purity of the NPs, colloidal stability, chemical composition,size, core-only or core-shell, 
nature and thickness of the shell layer, type of coating …) [13], 2) the nature of the experiments 
performed (e.g. differences in cell types, media composition, experimental procedures such as 
incubation times, concentrations used…) [14], 3) discrepancies between in vitro and in vivo data due 
to intrinsic differences in experimental setups (effect of agglomeration and sedimentation, effect of 
continuous flow versus static model) [15,16]. All these parameters influence the results obtained and 
therefore harden any comparison of toxicity data, generating a lot of confusion regarding the potential 
toxicity or safety of Cd2+-containing QDots. Although a recent pilot study indicated that these NPs do 
not cause any acute toxicity in non-human primates [17], long-term effects were not looked into and 
need to be considered carefully [18]. In vitro data often show high toxicity levels, which are to a large 
extent caused by the exposure of the QDots to their immediate biological (and degradative) 
environment, being cellular endo- or lyso-somes and their behavior in this complex biological 
environment, which results in leaching of free Cd2+ ions and thereby inducing toxicity [19-23]. 
To overcome these toxicity-related issues, a lot of focus has been put into optimizing QDot design to 
generate NPs with increased biocompatibility. One possibility lies in the generation of Cd2+-free 
QDots, but thus far, the synthesis of these QDots remains to be further optimized and a lot of effort is 
being put into increasing their optophysical properties to be in the same line as the Cd2+-containing 
ones [24,25]. The coating of the QDots can also be modified, where double polymer-silica coatings 
have been shown to enhance the resilience of the QDots against environmental degradation of the 
QDots [26]. A third option lies in modifying the chemical composition of the QDots, where the use of 
either core/shell/shell QDots or alternatively, so-called gradient alloy QDots have been put forward as 
powerful alternatives with excellent opticophysical properties [27-29]. Gradient alloy QDots consist 
out of a gradient internal structure (e.g. cadmium zinc selenide) which in contrast to particles with a 
homogeneous structure enables to achieve a fine tuning of the optical properties of the QDots without 
having to change particle size [30]. By modifying this gradient, gradient alloy QDots of the same size 
have been generated that can emit in the entire visible range [31]. Gradient alloy QDots also exhibit 
excellent opticophysical properties, including high quantum yields and photostability and resistance 
against surface etching [29]. Of specific interest, gradient alloy QDots have also, for the first time, 
been found to be able to be tuned into non-blinking QDots, exhibiting continuous photoluminescence 
[32]. This property renders them highly valuable for a multitude of applications, such as the 
continuous follow-up of single molecules in live cells [32,33]. 
Given these optimal features, gradient alloy QDots appear to be highly valuable alternatives to 
common coreeshell QDots, but their potential toxicity remains to be investigated thoroughly. To this 
end, the present work focuses on evaluating the cytotoxicity of two types of gradient alloy QDots 
(CdZnSe/ZnS) with emission maxima of 508 and 600 nm, respectively. A multiparametric analysis of 
particle toxicity is then performed according to previously established methods, in which a sequential 
analysis is made of QDot uptake, cytotoxicity, influence of endosomal pH, oxidative stress, cell 
morphology and cell functionality using a panel of three different cell types [14]. In the end, a 
concentration will be derived at which no effect can be observed for any of the parameters described 
above. As determining NP concentrations is a tedious task and prone to errors [13], this value does not 
allow for a straightforward comparison with other materials tested previously under identical 
conditions. Therefore, the functionality of the QDots will also be evaluated in terms of their ability to 
track live cells when labeled at non-toxic concentrations and this value can then be used to compare to 
other particles with the same functionality that have been tested previously, including different types 
of core-shell QDots [19,22]. Additionally, the effect of identical particle sizes but different emission 
spectra will also be tested in terms of the intracellular localization of the particles. In contrast to most 
QDot toxicity studies to date, the present study therefore addresses particle functionality at non-toxic 
levels and compares the data obtained to the data obtained for other types of QDot tested under 
identical conditions. The multiparametric methodology therefore enables to define the mechanisms 
underlying QDot toxicity and furthermore allows to compare the functionality of all different types of 
QDots previously tested under identical conditions, making it a very powerful technique. 
  
2. Materials and Methods 
2.1. Nanoparticles 
Two types of gradient alloy QDots were purchased from Mesolight LLC (Little Rock, Arkansas, 
USA). Both QDots contained a CdxZn1-xSe core and a ZnS shell. The differences in emission spectra 
are due to differences in the exact composition of core. The particles were provided as QDots with 
emission maxima at 508 and 600 nm. To ensure colloidal stability in an aqueous environment, the 
particles were both coated with 3-mercaptopropionic acid, resulting in a net negative charge for 
electrostatic repulsion. The particles were provided as 9 µM QDot stock solutions in alkaline H2O, pH 
11. For the effect of size on intracellular QDot distribution, two types of CdTe QDots (2.6 and 6.4 nm 
diameter, with emission maxima of 510 and 630 nm, respectively) were purchased from Plasmachem 
GmbH (Germany). These QDots were also coated with 3-mercaptopropionic acid, therefore having 
similar surface properties as the GA-QDots. 
2.2. Nanoparticle characterization 
2.2.1. Size determination by transmission electron microscopy 
The size of the QDots was determined by transmission electron microscopy (TEM) using a Cs 
corrected JEOL 2200 FS microscope operating at 200 kV.  
2.2.2. Elemental analysis 
The chemical composition of the QDots was determined by energy dispersive Xray spectroscopy 
(EDX) using the same microscope as for the TEM observations. 
2.2.3. Emission spectra 
Emission spectra of the QDots were recorded using a Quantifluor fluorometer (Promega, Belgium) 
with an excitation wavelength of 340 nm. 
2.2.4. Dynamic light scattering and electrophoretic mobility measurements 
The hydrodynamic diameter and -potential of both types of QDots were measured using a Nanosizer 
instrument (Malvern,Worcestershire, UK). To this end, the QDots were diluted (1/500) in phosphate 
buffered saline (PBS: 10 mM; pH 7.4) after which the measurements were performed (12 cycles/run) 
in triplicate. 
2.2.5. QDot sterility tests 
Both types of QDots were provided as sterile stock suspensions. To rule out the effect of any 
biological contaminants such as endotoxins, the common endpoint chromogenic QCL-1000® LAL 
assay (Lonza, Verviers, Belgium) was performed according to the manufacturer's instructions. 
2.3. QDot-cell interaction studies 
Following cellular exposure to the different QDots at various concentrations, the following parameters 
were evaluated: confocal microscopy of intracellular QDot localization and quantification of QDot 
clusters and quantitative levels of cell-associated QDots by fluorescence intensity measurements of 
lysed cells. The effect of the surrounding pH on QDot fluorescence intensity, and Cd2+ release was 
determined spectrophotometrically. Cell viability was evaluated in proliferating and non-proliferating 
cells (to determine the effect of intracellular QDot degradation on cellular health) using an Alamar 
blue assay. Oxidative stress was evaluated spectrofluorometrically using CellROX Green. Cell 
functionality was evaluated by fluorescence microscopy of HUVEC cells stained for actin and -
tubulin (cell spreading), C17.2 cells stained for TuJ-1 (neuronal differentiation), and PC12 cells 
stained for -tubulin (nerve growth factor-stimulated neurite outgrowth). Intracellular QDot 
distribution and endosomal localization of green and red-emitting GA-QDots and CdTe QDots were 
evaluated by confocal microscopy. Detailed experimental methodologies can be found in the 
Supporting information that accompanies this manuscript. 
2.4. Statistical analysis 
All data are expressed as mean ± SEM unless indicated otherwise and analyzed using one-way 
analysis of variance (ANOVA). Comparisons between particle-treated groups and untreated control 
groups were analyzed using the Dunnett post-hoc analysis method. In all cases, the degree of 
significance is indicated when appropriate (*: p < 0.05; **: p < 0.01; ***: p < 0.001). 
  
3. Results and Discussion 
3.1. Nanoparticle characterization 
The QDots (QDot500 and QDot600) were received as sterile colloidal suspensions where the particles 
were provided at a 9 µM stock concentration in alkaline H2O, pH 11. The presence of any endotoxins 
was evaluated using the common endpoint chromogenic QCL-1000® LAL assay, which did not show 
any endotoxins present in the QDot stock suspensions (data not shown). The QDots used in the present 
study had different emission maxima, being 508 and 600 nm, respectively (Supporting Fig. S1) and 
photoluminescence quantum yields of 41 and 90%. These values are in line with earlier reports on 
gradient alloy QDots, reaching very high PLQY compared to more classical coreeshell structured 
QDots [30]. The two types of QDots were therefore further defined as QDot500 and QDot600. The 
QDots used in the present study consist of a gradient layer of CdxZn1-xSe as core surrounded by a ZnS 
outer shell. Inside the core, the ratio of Cd and Zn varies, as demonstrated by elemental analysis 
(Table 1, Supporting Fig. S2) resulting in 2 QDot types of similar size (5.2 ± 0.8 nm for QDot500 
and 4.8 ± 0.7 nm for QDot600) as determined by transmission electron microscopy (Supporting Fig. 
S2). The difference in emission maxima therefore is linked to differences in the chemical composition 
of the QDots rather than differences in their size. The particles were both coated with short ligands, 
being 3-mercaptopropionic acid (MPA), which resulted in QDots with a negative surface charge of -34 
± 3 mV (QDot500) and -33 ± 2 mV (QDot600) as determined by electrophoretic mobility 
measurements. The particles were found to be rather stable in their alkaline environment, but upon 
transferring them to cell culture media, agglomerates were formed that remained stable for up to at 
least 24 h. The hydrodynamic diameter of both particles after 24 h exposure to cell culture media 
equals 117 ± 16 nm (QDot500) and 117 ± 14 nm (QDot600) (Supporting Fig. S3). 
3.2. Effect of endosomal pH on QDot fluorescence 
To evaluate how useful these QDots are for biological applications such as cell labeling, it is essential 
to assess the effect of the different environments to which the QDots will be exposed during its 
cellular internalization by the cell. Small NPs such as QDots are typically endocytosed by cultured 
cells [34], which results in their enclosure in endosomes and in a later phase, lysosomes, which are 
degradative cellular organelles that have a low pH (5.5 for endosomes, 4.5 for lysosomes). This low 
pH can affect the QDots by degrading their organic surface coating [35], following by acid etching of 
the QDot surface, resulting in a reduced PLQY and release of Zn2+ and Cd2+ ions [19,22]. The 
intracellular release of these ions has been shown to be an important mediator in QDot toxicity 
[36,37]. To evaluate how stable these gradient alloy QDots are against pH-dependent degradation, the 
effect of physiologically relevant pH levels on QDot properties (PLQY) was investigated, using 
previously established protocols as detailed in the Supporting Materials and methods. 
When the particles were exposed to citrate-containing buffer systems of pH 5.5 and 4.5, a clear 
reduction in fluorescence intensity of both types of QDots can be seen (Fig. 1). Interestingly, the loss 
in fluorescence intensity is far lower than previously observed for several types of CdSe/ZnS 
coreeshell QDots studied under identical conditions [19]. For the latter core-shell QDots after 5 days at 
pH 4.5, fluorescence intensity had dropped to approximately 40%. Together, these data show that the 
gradient alloy QDots studied in the present work appear to be more stable against pH-mediated 
degradation. This may be explained by the fact that the crystal structure of the alloy layer is more 
robust and less prone to environmentally induced defects such as oxidation, as shown for different 
types of GA-QDots that resulted in bright QDots with high PLQY, even after transfer from the organic 
to aqueous solvent [29]. The high brightness and pH-stability of the gradient alloy QDots suggest that 
these particles have a high potential for biological applications. 
3.3. Cellular uptake of gradient alloy QDots 
As the uptake mechanism and final intracellular localization of NPs may differ depending on the size 
of the NPs and their specific surface chemistry [34], the cellular uptake of the QDots was investigated. 
In the present work, three different cell types are used (murine C17.2 neural progenitor cells, primary 
human umbilical vein endothelial cells (HUVEC) and rat PC12 pheochromocytoma cells) that have 
previously been shown to have a high potential in cell therapy and which are excellent models for 
different tissue types [38,39]. Cells that were transiently expressing lysosomal associated membrane 
protein 1 (Lamp1) fused with a fluorescent protein (green or red) as a marker for late endosomal and 
lysosomal compartments were exposed to the QDots at concentrations up to 50 nM for 24 h. Cells 
were then analyzed by confocal microscopy, where the colocalization of the QDots and the lysosomal 
marker was analyzed (Fig. 2A). The data reveal a clear colocalization of either QDot500 or QDot600 
with the fluorescent lysosomes, indicating that both types of QDots were taken up by the cells through 
the process of endocytosis, as is the case for most types of NPs [34]. The gradient alloy QDots thus 
appear to finally reside in the lysosomal compartment of the cell, where they will be exposed to the 
low pH as described above. 
For toxicological purposes, it is also essential to quantify the number of NPs per cell as the total 
number of cell-associated NPs is often more important than the total number of NPs initially 
administered to the cells [22]. Particle toxicity can sometimes be reduced by applying an alternative 
coating to the NPs [40], which often results in a reduced cytotoxicity merely by decreasing cellular NP 
uptake. Therefore, in order to investigate NP toxicity, it is essential to correlate NP uptake levels with 
cellular toxicity. Additionally, for the purpose of cell labeling, the QDots used in the present study 
must exert a low toxicity while reaching high levels of intracellular NPs. Based on fluorescence 
images taken of cells exposed to the QDots for 24 h, the number of QDot-positive spots is determined 
(Fig. 2B, Supporting Fig. S4). This value indicates how well the QDots can be used to visualize the 
entire cell by fluorescence microscopy. However, for toxicity purposes, the number of QDot-positive 
vesicles is less interesting as QDots typically cluster together within the small luminal space of the 
endosomes and the number of QDots per endosome can vary a lot. Quantifying the total number of 
QDots per cell based on their fluorescence is not very straightforward, as the fluorescence intensity 
level of the QDots will be affected by the pH and ionic strength of their environment as well as by 
their state of agglomeration [41]. Therefore, the number of QDots per cell were quantitated using 
previously established protocols, in which labeled cells are slowly lysed in alkaline conditions, after 
which the number of QDots can be quantified more accurately [19]. Fig. 2C (Supporting Fig. S4) 
shows that both types of QDots have similar uptake levels, as expected by their similar size and 
identical surface chemistry. 
3.4. Acute and long-term toxicity and oxidative stress 
As the cellular uptake levels of either type of QDotwas sufficient to efficiently visualize labeled cells 
by fluorescence microscopy, the cytotoxicity of QDot500 and QDot600 was investigated (Fig. 3A, 
Supporting Fig. S5). The toxicity levels of both types of QDots were quite similar, where significant 
toxicity was observed at concentrations of 50 nM for C17.2 and HUVEC cells and at 40 nM for PC12 
cells. The seemingly higher level of toxicity of the QDots for PC12 cells seems contradictory to the 
observed cellular uptake levels, which are lowest for the PC12 cells. As NP toxicity is more closely 
correlated to the cellular NP level rather than the number of NPs originally administered to the cells 
[22], this would result in lower toxicity in PC12 cells. However, the PC12 cells, which are small cells 
with a limited cytoplasmic space, have been found to be very sensitive to cell stress [39]. Additionally, 
it has been shown that the size of the cell and its cytoplasm inversely correlates with the level of NP 
the cell can handle without any toxic effects [42]. As the toxic effects of QDots have been found to 
derive for a major part from the release of toxic Cd2+ or Zn2+ ions [23], the effect of possible QDot 
degradation on toxicity was also investigated using non-proliferating cell cultures (Fig. 3B). The data 
reveal no significant increase in toxicity up to 7 days for either type of QDot, which is in contrast to 
earlier studies with various types of core-shell QDots, where QDot toxicity increased with time 
[19,22]. These data again demonstrate the high stability of the QDots against intraendosomal 
degradation. 
As NP toxicity, including QDot toxicity, has been shown to be related to the induction of reactive 
oxygen species (ROS), the cellular ROS levels were determined (Fig. 3C, Supporting Fig. S6). The 
data reveal a clear concentration-dependent induction of oxidative stress in all cell types, which is of a 
similar level for both types of QDots. The level of oxidative stress correlates with the degree of 
toxicity, suggesting that oxidative stress may be an important cause of the observed cytotoxicity. 
However, the level of oxidative stress does not correlate with the number of cell-associated QDots. 
PC12 cells display the highest level of toxicity and oxidative stress, although these cells contain the 
lowest number of cell-associated QDots. This apparent discrepancy corresponds to differences in the 
sensitivity of different cells to foreign material as well as with differences in their antioxidative 
capacity [43]. This has been observed in different studies [19,43] and highlights the need for the use of 
multiple cell types when assessing particle toxicity in order to obtain a more general overview. To 
verify the correlation between oxidative stress and cytotoxicity, cells were co-treated with N-
acetylcystein (NAC), an FDA-approved free radical scavenger, which reduced cellular ROS to near 
control levels (Supporting Fig. S6). The addition of NAC also reduced cytotoxicity to a large extent 
(Fig. 3D, Supporting Fig. S5), indicating the importance of ROS in the observed cytotoxicity of the 
QDots, which is in line with many other studies [44]. 
3.5. Effect of QDots on cell functionality 
Many different types of NPs have also been found to affect cellular morphology [14,45], for instance 
by deregulation of the cytoskeletal architecture of the cells [46]. These effects have been found to 
occur at conditions at which the NPs did not cause any acute cytotoxicity [47]. As the actin and 
tubulin cytoskeleton are very important mediators in various cell signaling pathways [48], and as for 
bio-imaging purposes it is essential that cells maintain their original morphology, the effect of 
QDot500 and QDot600 on HUVEC morphology was investigated. Fig. 4A shows a clear distribution 
of the cell areas of the HUVEC cells exposed to the QDots at concentrations up to 30 nM (below the 
threshold for any cytotoxicity or oxidative stress to occur as high levels of cell death or ROS would 
influence the outcome of these results) calculated for various images of treated cells stained for F-actin 
and -tubulin (Fig. 4B). The data clearly show that both types of QDots affect cell morphology at 
concentrations of 20 nM, again revealing the great similarity between both types of QDots in terms of 
their effect on cultured cells. 
As NPs can interact with cultured cells through a wide variety of different mechanisms [49], it is 
important to verify the functionality of the cells after cell labeling. For C17.2 and PC12 cells, the 
functionality of the cells was not investigated by their cellular spreading, as these cells are more 
rounded and have a less well-defined cytoskeleton, which hardens any straightforward analysis. 
Therefore, functionality of C17.2 and PC12 cells was investigated by means of cellular differentiation 
and neurite outgrowth assays, respectively. Fig. 4C shows that C17.2 differentiation is slightly 
affected by QDot exposure, where significant effects are observed at concentrations of 20 nM or 
above. Fig. 4D shows that neurite outgrowth of PC12 cells is significantly impeded at concentrations 
of 15 nM or higher. The higher sensitivity of the PC12 cells compared to C17.2 or HUVEC cells is 
somewhat surprising, given the lower cellular uptake and lower ROS levels in the PC12 cells. This 
difference may be explained by differences in the cell types, where PC12 cells themselves are 
inherently smaller than the C17.2 or HUVEC cells and can thus maximally accommodate a lower 
number of NPs in the restricted space of their cytoplasm, which may result in a higher sensitivity of 
the smaller (PC12) cells [42]. Alternatively, the higher sensitivity of the PC12 cells can also be due to 
the fact that the natural defense mechanisms (e.g. antioxidants) in the PC12 cells may be lower, which 
would make the cells more sensitive to (oxidative) stress [43]. A final reason for this difference may 
lie in the assay itself. Cell morphology assays are inherently not very sensitive due to the broad 
distribution of cell areas. Cell differentiation assays such as performed for the C17.2 cells are also less 
sensitive as they take several days to perform, during which time the number of QDots per cell may 
have diluted. Furthermore, during the differentiation process, the cells undergo high levels of stress 
and the assay is accompanied by significant cell death [50]. Due to this, the cells that contain the 
highest number of NPs might die and the assay itself will mostly represent cells with lower numbers of 
NPs and may thus not be a completely accurate overview of NP toxicity. The PC12 neurite outgrowth 
assay has however been shown to be a very sensitive assay that can be rapidly performed with 
minimal stress on the cultured cells, thus being optimally suited for determining NP toxicity [51]. 
3.6. Usefulness of QDots for cell labeling 
Based on the different experiments performed, the various assays showed that both types of QDots did 
not affect any cellular parameter at concentrations up to 10 nM. Therefore, the safe concentration for 
cell labeling was determined at 10 nM. To determine how useful the gradient alloy QDots are for cell 
labeling, their functionality must however be assessed at their non-toxic concentration. Therefore, the 
QDots were used to label the different cell types at 10 nM, after which the cells were kept in culture 
and imaged every 2 days to see how long the cells can be efficiently visualized. Fig. 5 shows that the 
QDots can be used to monitor every type of cell for up to at least 6 cell doublings before the number 
of QDots is diluted too much due to continuous cell division. 
The QDots appear to be quite well suited for cell labeling experiments. Previous studies on core-shell 
QDots investigated under identical conditions resulted in toxic levels of 0.5-2 nM [19,22], which is 
approximately 5-fold lower than the level found for the gradient alloy QDots examined in the current 
study. This value is however quite insignificant as determining the concentration of NPs is technically 
very challenging [13]. A direct comparison of NP toxicity based on no-observed adverse effect levels 
(NOAELs) is therefore often quite difficult and prone to errors based on incorrect determination of the 
original particle concentration. Determination of particle functionality, such as the visualization of 
labeled cells by fluorescence microscopy is therefore a far better alternative. When comparing the 
efficiency of cell visualization, the gradient alloy QDots allow 50% of the cell population to be seen 
after 6 cell doublings, where the core-shell QDots studied previously under identical conditions led to 
cell visualization for 4 doublings [19,22]. This suggests that the gradient alloy QDots are 
approximately 1.5-fold more efficiently for cell visualization than the core-shell QDots. This value is a 
lot lower than the 5-fold increase in efficiency based on NOAELs and might be due to various factors, 
such as inaccurate determination of QDot concentrations or differences in the surface chemistry of the 
QDots, where the short ligands used in the current study are known to result in less colloidal stability 
and hence less cellular uptake than more stable polymer-coated QDots [52]. In conclusion, the 
gradient alloy QDots do have a big potential for cell labeling studies, where their high brightness and 
chemical stability result in good probes for long term cell visualization. Further improvements lie in 
the surface chemistry of the QDots, where polymer or silica coatings may enhance colloidal and 
chemical stability and improve cellular uptake levels. 
The present study has, in contrast to most nanotoxicity studies, addressed the actual functionality of 
the QDots at their non-toxic concentration rather than providing a “safe concentration”. Many studies 
also focus on the mechanisms of QDot toxicity and therefore employ CdTe core-only QDots 
[20,23,46,53], which are known to be much more toxic than the core-shell QDots. The current study 
focuses on QDots that have a great potential for biomedical use and seeks to assess the potential of 
these QDots for their intended purpose of fluorescence-based imaging at non-toxic conditions. Using 
the multiparametric methodology, the values obtained can then also immediately be compared to those 
obtained for other types of QDots that were studied under identical conditions [19,22]. Placing the 
currently studied QDots in relation to various other types of QDots in terms of their functionality 
greatly enhances the power of the current study in contrast to most stand-alone studies, where it is 
almost impossible to make a proper comparison between results due to differences in the study designs 
and lack of appropriate standards being used. 
3.7. The effect of similar sizes with regard to intracellular QDot localization 
Common core-only or coreeshell QDots can span the entire visible range by altering the size of the 
QDot cores. QDots of different sizes have been found to reach different intracellular localizations [53]. 
Gradient alloy QDots can span the entire visible range while having identical sizes. As the particles 
studied in the present work also have identical surface chemistry, their intracellular localization may 
be more similar. This was tested by co-exposing cultured cells to QDot500 and QDot600 particles at 
10 nM concentrations for 24 h (Fig. 6A), after which their intracellular localization was compared to 
cells exposed to MPA-coated CdTe QDots of 2.6 and 6.4 nm diameter (510 and 630 nm wavelength, 
respectively) (Fig. 6B). These data clearly show a uniform labeling of the cells by the gradient alloy 
QDots, where colocalization of the two types of QDots reaches 91 ± 7%. For the CdTe QDots that 
differ widely in size (2.6e6.4 nm) but have identical surface coating, their intracellular localization 
patterns differ more, where colocalization is limited to 58 ± 9%. The differences in intracellular 
localization of the QDots depending on their size is in line with earlier studies, where smaller QDots 
were found to reach different intracellular organelles than bigger sized QDots [53]. 
This size-dependent intracellular localization may be useful in certain conditions, if specific organelles 
would be targeted that cannot be reached by larger sized particles. However, to date, our 
understanding of the link between NP size and their precise intracellular location is still unclear and 
more research would be needed in order to be able to fully exploit this property for cell labeling or 
delivery purposes. Therefore, current methods to enable intracellular targeting are mostly limited to 
the use of surface attached ligands to specific cellular markers [54]. However, considering the 
difference in intracellular distribution of the QDots depending on their size, the addition of certain 
targeting moieties does not always give the expected results as these particles undergo different 
endocytic routes and particles of certain sizes may be hindered to reach their target site. Alternatively, 
as the gradient alloy QDots can be made of the same size and reach the same intracellular locations, 
this presents particularly useful properties with regard to their potential targeting capacities. As all 
QDots, regardless of their emission maxima, have the same size and surface characteristics, they will 
have the same intracellular distribution. This will make targeting methods by altering their surface 
coating more straightforward. 
  
4. Conclusions 
The present work shows that GA-QDots have a high brightness and high chemical stability that 
appears to protect them for environmentally induced degradation. These parameters result in relatively 
low levels of cytotoxicity compared to common core-shell QDots. The differences in chemical 
composition of the QDot cores appear to only have a minimal effect on the extent and nature of cell-
QDot interaction, where cellular uptake levels and toxicity levels were similar for the two types of 
GA-QDots for all parameters studied. The data show that the GA-QDots are less toxic than common 
core-shell QDots, and affect cells through induction of ROS, disturbance of cell cytoskeletal 
architecture and impeded neuronal differentiation. However, when also assessing particle 
functionality, the difference between GA-QDots and common core-shell QDots is not as high as 
would be expected from comparing non-toxic concentrations. This difference stipulates the importance 
of using particle functionality for comparative purposes as particle concentrations are less appropriate, 
given that they do not take into account multiple important factors such as differences in particle 
brightness, differences in cellular uptake levels or possible errors in determining nanoparticle stock 
concentrations. The identical size of the GA-QDots furthermore offers a lot of interesting 
opportunities for cell labeling applications, such as drug delivery. Where common QDots with 
different emission maxima and thus different sizes result in quite different intracellular particle 
distributions, this is not the case for the GA-QDots, which given their identical sizes result in highly 
similar intracellular particle distributions. This finding offers a lot of potential for optimizing drug 
delivery studies, where the impact of the size of the delivery vehicle on its intracellular location is very 
important and should be optimized in terms of the final application of the nanomaterials. 
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Table 1 
Elemental composition of QDot500 and QDot600. 
Zn   Se   Cd   S 
QDot500   68 ± 6   1 ± 1%  1 ± 1%  30 ± 6% 






Fig. 1. The fluorescence intensity levels of QDot500 and QDot600 exposed to buffer systems of 
different pH values, being 7.4 (cytoplasmic); 5.5 (late endosomes) or 4.5 (lysosomes) for up to 5 days. 
Fluorescence intensity levels were measured every day. Data are presented as values relative to the 
fluorescence intensity of QDots exposed to pH 7.4 and measured immediately (day 0 ¼ 100%). Data 







Fig. 2. Cellular uptake of QDots. (A) Representative confocal images of HUVEC cells transiently 
expressing fluorescently tagged Lamp-1 (marker for late endosomes and lysosomes) incubated with 30 
nM QDot500 (top row; green channel) or QDot600 (bottom row; red channel) for 24 h. Cells exposed 
to QDot500 are tagged with Lamp-1-RFP (red channel); cells exposed to QDot600 are tagged with 
Lamp-1-GFP. A merged image of both the QDots and the fluorescently tagged endosomes is shown in 
the right column. The area indicated by the white rectangle in the merged images is shown in high 
resolution on the right. Scale bars: 40 µm. (B) The number of QDot clusters per cell as a function of 
the QDot concentration for both QDot500 (light gray) and QDot600 (dark gray) as quantified from 20 
microscopy images. (C) The total number of QDots per HUVEC cell as a function of the QDot 
concentration for both QDot500 (light gray) and QDot600 (dark gray) as quantified by measuring total 
fluorescence intensity levels. Data are shown as mean ± SEM (n = 4). 
 
Fig. 3. (A) Viability of HUVEC cells as a function of QDot concentration (ranging from 10 to 60 nM) 
for both QDot500 (light gray) and QDot600 (dark gray) after 24 h incubation. (B) Viability of non-
proliferating HUVEC cells as a function of both QDot concentrations (30, 40 and 50 nM) and time (1-
7 days post-QDot incubation). (C) ROS levels of HUVEC cells exposed to varying concentrations (10-
60 nM) of QDot500 (light gray) or QDot600 (dark gray). (D) Viability of HUVEC cells as a function 
of QDot concentration (ranging from 10 to 60 nM) for both QDot500 (light gray) and QDot600 (dark 
gray) after 24 h incubation in the presence of 5 mM NAC, a free radical scavenger. Data are 
represented as mean ± SEM (n = 4) and expressed as relative to untreated control cells (100%) or for 
figure B as treated cells at day 0 (100%). The degree of significance is indicated when appropriate (*: 




Fig. 4. (A) Representative fluorescence images of HUVEC cells either untreated (top row) or exposed 
to 10 nM QDot500 (second row), 25 nM QDot500 (third row), 10 nM QDot600 (fourth row) or 25 nM 
QDot600 (bottom row) for 24 h. Cells have been stained for F-actin (red, left column) and -tubulin 
(green, middle column). The right column shows a merged image of both the green and red channel. 
Scale bars: 150 µm. (B) The average cell area of HUVEC cells as a function of QDot concentration 
(ranging from 0 to 30 nM) for both QDot500 (light gray) and QDot600 (dark gray) after 24 h 
incubation. (C) The level of C17.2 cells that differentiated into full neurons upon 1 week exposure to 
neuronal induction media as a function of QDot concentration (ranging from 0 to 30 nM) for both 
QDot500 (light gray) and QDot600 (dark gray) after 24 h incubation. (D) The level of PC12 neurite 
outgrowth upon 2 days exposure to nerve growth factor as a function of QDot concentration (ranging 
from 0 to 30 nM) for both QDot500 (light gray) and QDot600 (dark gray) after 24 h incubation. (B-D) 
Data are expressed as mean ± SEM (n = 4). The degree of significance is indicated when appropriate 
(*: p < 0.05; **: p < 0.01; ***: p < 0.001). 
 
 
Fig. 5. (A) Representative fluorescence images of HUVEC cells exposed to non-cytotoxic 
concentrations of QDot600 (10 nM; top row) or QDot500 (10 nM; bottom row) for 24 h, after which 
the cells were kept in culture. The images shown are taken immediately after QDot exposure (D0) or 
after 2 (D2), 4 (D4) or 6 (D6) average cell doubling times. The images are merged images of the 
fluorescent QDots (QDot500: green; QDot600: red) and phase contrast images of the cells. Scale bars: 
150 µm. (B-D) The percentage of (B) C17.2, (C) HUVEC or (D) PC12 cells containing QDot500 
(light gray) or QDot600 (dark gray) upon further culture of pre-incubated cells. The data are expressed 
as a function of the number of cell divisions the cells underwent post-incubation. Data are given as 
mean ± SEM (n = 4). 
 
 
Fig. 6. Representative fluorescence images of HUVEC cells co-incubated with green and red QDots 
for 24 h, either GA-QDots of similar size (top row) or MPA-coated CdTe QDots of different sizes 
(bottom row). Cell nuclei were counterstained with DAPI (blue; third column). The fourth column 
shows merged images of the green, red and blue channel. The area indicated by the rectangle in the 
merged images is displayed as a magnified inset in the fifth column revealing high colocalization of 
the GA-QDots compared to lower levels of colocalization for the CdTe QDots. Scale bars: 150 µm. 
